L. Corroller, A. G. Moatti, and J. P. , The economic evaluation of hematopoietic growth factors in high dose chemotherapy, Anti Cancer Drugs, vol.9, pp.917-924, 1998.

A. M. Smith and A. Keating, Peripheral blood progenitor cell transplantation: clinical, practical and economic considerations, J Hematother, vol.3, pp.331-348, 1994.

C. A. Uyl-de-groot, G. J. Ossenkoppele, A. Van-riet, and F. Rutten, The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myeloma, Eur J Cancer, vol.30, pp.457-459, 1994.

O. Hartmann, L. Corroller, A. G. Blaise, D. Michon, J. Philip et al., Peripheral blood stem cells and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized controlled trial, Ann Intern Med, vol.126, pp.600-607, 1997.

A. Anastasia, F. Giglio, R. Mazza, B. Sarina, E. Todisco et al., Early discharge after high-dose melphalan and peripheral blood stem cell reinfusion in patients with hematological and non-hematological disease, Leuk Lymphoma, vol.50, pp.80-84, 2009.

F. Fernandez-aviles, E. Carreras, A. Urbano-ispizua, M. Rovira, C. Martinez et al., Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies, J Clin Oncol, vol.24, pp.4855-4861, 2006.

F. Ferrara, S. Palmieri, A. Viola, C. Copia, E. M. Schiavone et al., Outpatient-based peripheral blood stem cell transplantation for patients with multiple myeloma, Hematol J, vol.5, pp.222-226, 2004.

M. Freeman, J. Vose, C. Bennett, J. Anderson, A. Kessinger et al., Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center, Bone Marrow Transplant, vol.24, pp.679-684, 1989.

P. Frey, T. Stinson, A. Siston, S. J. Knight, E. Ferdman et al., Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program, Bone Marrow Transplant, vol.30, pp.741-748, 2002.

S. Gluck, C. Des-rochers, C. Cano, M. Dorreen, C. Germond et al., High-dose chemotherapy followed by autologous blood cell transplantation: a safe and effective outpatient approach, Bone Marrow Transplant, vol.20, pp.431-434, 1997.

S. Jagannath, D. H. Vesole, M. Zhang, K. R. Desikan, N. Copeland et al., Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma, Bone Marrow Transplant, vol.20, pp.445-450, 1997.

C. Leger, M. Sabloff, S. Mcdiarmid, I. Bence-bruckler, H. Atkins et al., Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma, Ann Hematol, vol.85, pp.723-729, 2006.

S. Mcdiarmid, B. Hutton, H. Atkins, I. Bence-bruckler, C. Bredeson et al., Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes, Bone Marrow Transplant, vol.45, pp.1220-1226, 2010.

B. R. Meisenberg, W. E. Miller, R. Mcmillan, M. Callaghan, C. Sloan et al., Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies, J Clin Oncol, vol.15, pp.11-17, 1997.

W. P. Peters, M. Ross, J. Vredenburgh, A. Hussein, P. Rubin et al., The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer, Semin Oncol, vol.21, issue.7, pp.25-31, 1994.

J. D. Rizzo, G. B. Vogelsang, S. Krumm, B. Frink, V. Mock et al., Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting?, J Clin Oncol, vol.17, pp.2811-2818, 1999.

N. Summers, U. Dawe, and D. A. Stewart, A comparison of inpatient and outpatient ASCT, Bone Marrow Transplant, vol.26, pp.389-395, 2000.

J. Mehta and F. L. Dulley, Outpatient or inpatient stem cell transplantation: patria est ubicunque est bene?, Leuk Lymphoma, vol.50, pp.3-5, 2009.

S. P. Dix and R. B. Geller, High-dose chemotherapy with autologous stem cell rescue in the outpatient setting, Oncology (Huntingt), vol.14, pp.91-92, 2000.

W. P. Peters, M. Ross, J. J. Vredenburgh, A. Hussein, P. Rubin et al., The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer, Semin Oncol, vol.21, issue.7, pp.25-31, 1994.

M. Rovira, Outpatient management of autologous haematopoietic cell transplantation: the Barcelona experience, Presse Med, vol.33, pp.479-481, 2004.

A. M. Westermann, M. M. Holtkamp, G. A. Linthorst, L. Van-leeuwen, E. J. Willemse et al., At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies, Ann Oncol, vol.10, pp.511-517, 1999.

P. Stiff, P. Mumby, L. Miler, T. Rodriguez, M. Parthswarthy et al., Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis, Bone Marrow Transplant, vol.38, pp.757-764, 2006.